In 2006, the AG Holding Group started its Biomedical Distribution Cluster through establishing the AGBL Distribution Group which focused on the emerging markets of the Middle East, Africa, and Asia.
Over the years, the Biomedical Distribution Cluster established a strong presence across the MEAA region. The AG Holding Group diversified its investments in the healthcare sector to include Diagnostic and Research Laboratory services. The group also invested in the Diagnostics Products manufacturing space.
The AG Holding Group took interest in the field of data and information technology (IT) with investments in a number companies to solidify its position and vision to lead the data and digital innovation in emerging markets. Today, AG Holding employs the same distribution philosophy of improving lives through science that it began with to make a difference in the health and wellness sector.
